Real-time enrollment status for this diabetic macular edema clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 10:21 AM UTC
| NCT Number | NCT07425522 |
| Recruiting Status | Recruiting |
| Condition | Diabetic Macular Edema |
| Phase | PHASE1 |
| Target Enrollment | 93 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Genentech, Inc. |
| Last Updated on CT.gov | August 14, 2026 (1 week ago) |
As of August 27, 2026: Clinical trial NCT07425522 is currently recruiting participants. This phase1 study for diabetic macular edema is actively seeking new participants at 12 locations across the United States. The study is sponsored by Genentech, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07425522 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07425522 was last updated 1 week ago (August 14, 2026). HelloStudys verifies this status automatically.